Scientist receives abstract award
Click Here to Manage Email Alerts
Songbing Qin, MD, a visiting scientist to The Cancer Institute of New Jersey, received the International — U.S. Annual Meeting Scientific Abstract Award at the 54th Annual Meeting of the American Society for Radiation Oncology.
The award recognizes outstanding abstracts submitted by clinicians early in their careers. Qin was selected for his submission, titled "Motion Pattern for Liver Tumor and its Correlation to External Surrogates."
Qin, who works at First Affiliated Hospital of Soochow University in Taiwan, was a visiting scientist at The Cancer Institute of New Jersey from April 2011 to April 2012.
Stereotactic body radiotherapy (SBRT) is a type of therapy in which large doses of radiation are delivered in fewer than five treatments. SBRT has been used to treat liver tumors that often exhibit significant movement while a treatment is being administered. The efficacy of SBRT on liver tumors may hinge on fully understanding tumor motion patterns and successful motion management since motion may complicate the treatment process or even compromise treatment outcomes.
Qin and colleagues investigated the motion pattern and magnitude of liver tumors and the correlation with external surrogates. Their research concluded that direct internal monitoring of liver tumors may be required for improved motion management.
"It is vital to recognize young scientists in this way, as they are the future of radiation oncology investigation. Dr. Qin’s research represents the foundation of advances to come in our field, and it is exciting to see he is receiving international recognition for his efforts," Ning J. Yue, PhD, FAAPM, who leads the radiation physics team at The Cancer Institute of New Jersey, said in a press release.